《大行报告》美银证券:内银股去年纯利胜预期 首选工行、农行及建行
美银证券发表报告表示,多数内银股去年纯利按年升1%至5%,高於该行预期2%至7%,而民生银行(01988.HK)及重农行(03618.HK)除外。行业去年核心盈利增幅由2019年度之11%降至去年5%,资本回报率下跌1.4个百分点至11.2%。
该行指,自去年第四季开始对内银股转趋乐观,且预期今年行业盈利增长及估值会回复正常;内银板块本年至今累升14%,跑赢MSCI中国指数、恒指及恒生中国H股金融行业指数分别14个、10个及6个百分点,该行持续看好大型内银股,主因其高收益率及在紧缩环境中的有利位置,首选工行(01398.HK)、农行(01288.HK)及建行(00939.HK)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.